Monounsaturated and Diunsaturated Fatty Acids Sensitize Cervical Cancer to Radiation Therapy

Overview

Journal Cancer Res

Specialty Oncology

Date 2022 Oct 10

PMID 36214635

Authors

Naoshad Muhammad

Fiona Ruiz

Jennifer Stanley

Ramachandran Rashmi

Kevin Cho

Kay Jayachandran

Michael C Zahner

Yi Huang

Jin Zhang

Stephanie Markovina

Gary J Patti

Julie K Schwarz

Affiliations

Soon will be listed here.

Abstract

Significance: Metabolism of monounsaturated and diunsaturated fatty acids improves the efficacy of radiotherapy in cancer through modulation of p53 activity. See related commentary by Jungles and Green, p. 4513.

Citing Articles

Effect of weight loss following Roux-en-Y gastric bypass on cancer risk: A Mendelian randomization study.

Xue J, Chen S, Wang Y, Jiao Y, Wang D, Zhao J Medicine (Baltimore). 2025; 104(5):e41351.

PMID: 39889174 PMC: 11789913. DOI: 10.1097/MD.0000000000041351.

Biological Insights and Radiation-Immuno-Oncology Developments in Primary and Secondary Brain Tumors.

Gregucci F, Beal K, Knisely J, Pagnini P, Fiorentino A, Bonzano E Cancers (Basel). 2024; 16(11).

PMID: 38893165 PMC: 11171192. DOI: 10.3390/cancers16112047.

MicroRNA-875-5p inhibits the growth and metastasis of cervical cancer cells by promoting autophagy and apoptosis and inhibiting the epithelial-mesenchymal transition.

Liang Y, Li C, Hou X, Lin Y, Cheng J Front Oncol. 2024; 14:1361721.

PMID: 38800376 PMC: 11116804. DOI: 10.3389/fonc.2024.1361721.

Plasma free fatty acid levels in cervical cancer: concurrent chemoradiotherapy improves abnormal profile.

Xu X, Ping P, Zhang Z, Zou L Front Pharmacol. 2024; 15:1352101.

PMID: 38449803 PMC: 10916716. DOI: 10.3389/fphar.2024.1352101.

Reprogramming of lipid metabolism in the tumor microenvironment: a strategy for tumor immunotherapy.

Wu Y, Pu X, Wang X, Xu M Lipids Health Dis. 2024; 23(1):35.

PMID: 38302980 PMC: 10832245. DOI: 10.1186/s12944-024-02024-0.

References

Yaghoubizadeh M, Pishkar L, Basati G . Aberrant Expression of Peroxisome Proliferator-Activated Receptors in Colorectal Cancer and Their Association with Cancer Progression and Prognosis. Gastrointest Tumors. 2020; 7(1-2):11-20. PMC: 7206611. DOI: 10.1159/000503995. View

Magtanong L, Ko P, Dixon S . Emerging roles for lipids in non-apoptotic cell death. Cell Death Differ. 2016; 23(7):1099-109. PMC: 5399169. DOI: 10.1038/cdd.2016.25. View

Psychogios N, Hau D, Peng J, Guo A, Mandal R, Bouatra S . The human serum metabolome. PLoS One. 2011; 6(2):e16957. PMC: 3040193. DOI: 10.1371/journal.pone.0016957. View

Lei G, Mao C, Yan Y, Zhuang L, Gan B . Ferroptosis, radiotherapy, and combination therapeutic strategies. Protein Cell. 2021; 12(11):836-857. PMC: 8563889. DOI: 10.1007/s13238-021-00841-y. View

Jiang W, Douglas-Jones A, Mansel R . Expression of peroxisome-proliferator activated receptor-gamma (PPARgamma) and the PPARgamma co-activator, PGC-1, in human breast cancer correlates with clinical outcomes. Int J Cancer. 2003; 106(5):752-7. DOI: 10.1002/ijc.11302. View

Yang W, Kim K, Gaschler M, Patel M, Shchepinov M, Stockwell B . Peroxidation of polyunsaturated fatty acids by lipoxygenases drives ferroptosis. Proc Natl Acad Sci U S A. 2016; 113(34):E4966-75. PMC: 5003261. DOI: 10.1073/pnas.1603244113. View

Stockwell B, Friedmann Angeli J, Bayir H, Bush A, Conrad M, Dixon S . Ferroptosis: A Regulated Cell Death Nexus Linking Metabolism, Redox Biology, and Disease. Cell. 2017; 171(2):273-285. PMC: 5685180. DOI: 10.1016/j.cell.2017.09.021. View

Bonofiglio D, Cione E, Vizza D, Perri M, Pingitore A, Qi H . Bid as a potential target of apoptotic effects exerted by low doses of PPARγ and RXR ligands in breast cancer cells. Cell Cycle. 2011; 10(14):2344-54. DOI: 10.4161/cc.10.14.15917. View

Cao Y, Ma J . Body mass index, prostate cancer-specific mortality, and biochemical recurrence: a systematic review and meta-analysis. Cancer Prev Res (Phila). 2011; 4(4):486-501. PMC: 3071449. DOI: 10.1158/1940-6207.CAPR-10-0229. View

10.

Bersuker K, Hendricks J, Li Z, Magtanong L, Ford B, Tang P . The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis. Nature. 2019; 575(7784):688-692. PMC: 6883167. DOI: 10.1038/s41586-019-1705-2. View

11.

Rashmi R, Huang X, Floberg J, Elhammali A, McCormick M, Patti G . Radioresistant Cervical Cancers Are Sensitive to Inhibition of Glycolysis and Redox Metabolism. Cancer Res. 2018; 78(6):1392-1403. PMC: 5856626. DOI: 10.1158/0008-5472.CAN-17-2367. View

12.

Patel V, James M, Frampton C, Robinson B, Davey V, Timmings L . Body Mass Index and Outcomes in Breast Cancer Treated With Breast Conservation. Int J Radiat Oncol Biol Phys. 2019; 106(2):369-376. DOI: 10.1016/j.ijrobp.2019.09.049. View

13.

Ye L, Chaudhary K, Zandkarimi F, Harken A, Kinslow C, Upadhyayula P . Radiation-Induced Lipid Peroxidation Triggers Ferroptosis and Synergizes with Ferroptosis Inducers. ACS Chem Biol. 2020; 15(2):469-484. PMC: 7180072. DOI: 10.1021/acschembio.9b00939. View

14.

Slawinski C, Barriuso J, Guo H, Renehan A . Obesity and Cancer Treatment Outcomes: Interpreting the Complex Evidence. Clin Oncol (R Coll Radiol). 2020; 32(9):591-608. DOI: 10.1016/j.clon.2020.05.004. View

15.

Zou Y, Palte M, Deik A, Li H, Eaton J, Wang W . A GPX4-dependent cancer cell state underlies the clear-cell morphology and confers sensitivity to ferroptosis. Nat Commun. 2019; 10(1):1617. PMC: 6453886. DOI: 10.1038/s41467-019-09277-9. View

16.

Doll S, Proneth B, Tyurina Y, Panzilius E, Kobayashi S, Ingold I . ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition. Nat Chem Biol. 2016; 13(1):91-98. PMC: 5610546. DOI: 10.1038/nchembio.2239. View

17.

Davies B, Walsh T, Ross P, Knight S, Sadetsky N, Carroll P . Effect of BMI on primary treatment of prostate cancer. Urology. 2008; 72(2):406-11. DOI: 10.1016/j.urology.2007.11.032. View

18.

Rashmi R, Jayachandran K, Zhang J, Menon V, Muhammad N, Zahner M . Glutaminase Inhibitors Induce Thiol-Mediated Oxidative Stress and Radiosensitization in Treatment-Resistant Cervical Cancers. Mol Cancer Ther. 2020; 19(12):2465-2475. PMC: 8208465. DOI: 10.1158/1535-7163.MCT-20-0271. View

19.

Terashita Y, Sasaki H, Haruki N, Nishiwaki T, Ishiguro H, Shibata Y . Decreased peroxisome proliferator-activated receptor gamma gene expression is correlated with poor prognosis in patients with esophageal cancer. Jpn J Clin Oncol. 2002; 32(7):238-43. DOI: 10.1093/jjco/hyf056. View

20.

Yang W, Sriramaratnam R, Welsch M, Shimada K, Skouta R, Viswanathan V . Regulation of ferroptotic cancer cell death by GPX4. Cell. 2014; 156(1-2):317-331. PMC: 4076414. DOI: 10.1016/j.cell.2013.12.010. View